Search clinical trials for: Rivaroxaban 20 MG
Total 11584 results
-
BayerCompleted
-
The Affiliated Hospital of Qingdao UniversityCompletedHealthy SubjectsChina
-
Korea University Anam HospitalRecruitingAtrial Fibrillation | Anticoagulant Adverse ReactionKorea, Republic of
-
Janssen Research & Development, LLCBayerCompleted
-
Doasense GmbHActive, not recruitingAnticoagulant TherapyGermany
-
University Hospital, AngersBayerRecruiting
-
Pharmtechnology LLCClinPharmInvest, LLCNot yet recruitingBioequivalenceRussian Federation
-
Addpharma Inc.CompletedEmbolism and ThrombosisKorea, Republic of
-
University of KarachiCenter for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research... and other collaboratorsCompleted
-
Capital Medical UniversityCompleted
-
Cardioangiologisches Centrum BethanienActive, not recruitingHeavy Menstrual BleedingGermany
-
Vanda PharmaceuticalsCompletedNon-24-Hour-Sleep-Wake Disorder
-
University Hospital, BrestBayerCompletedMorbid Obesity | Bariatric SurgeryFrance
-
The Young Investigator Group of Cardiovascular...CompletedLeft Ventricular Thrombosis | Anticoagulants; IncreasedEgypt
-
Eisai Co., Ltd.Completed
-
VarmX B.V.RecruitingCoagulation DisorderNetherlands
-
Portola PharmaceuticalsCompletedBleedingUnited States
-
University of Sao Paulo General HospitalRecruiting
-
BayerCompletedPharmacokineticsGermany
-
Peking Union Medical College HospitalNot yet recruiting
-
PfizerCompleted
-
Janssen Research & Development, LLCCompleted
-
Hospital Geral Roberto SantosTerminatedStroke | Valve Heart Disease | Anticoagulants and Bleeding Disorders | Prostheses and ImplantsBrazil
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
Tourmaline Bio, Inc.RecruitingThyroid Eye DiseaseUnited States, Jordan
-
Xenon Pharmaceuticals Inc.CompletedMajor Depressive DisorderUnited States
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
PfizerCompletedHealthy | Diabetes Mellitus, Type 2 | Renal ImpairmentUnited States
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGActive, not recruiting
-
University of UtahCompleted
-
AstraZenecaCompletedGastric Ulcer | Duodenal Ulcer | Reflux Esophagitis | Anastomotic Ulcer | Etc.Japan
-
Daiichi Sankyo, Inc.CompletedAtopic DermatitisUnited States
-
University of BolognaIpsen; Bioikos Ambiente Srl; AOU S.Orsola Malpighi-Unit of Oncologic Molecular... and other collaboratorsUnknownNon Small Cell Lung CancerItaly
-
Intra-Cellular Therapies, Inc.RecruitingHealthy VolunteersUnited States
-
Addpharma Inc.CompletedHypertension | HyperlipidemiasKorea, Republic of
-
Eisai Inc.CompletedPurpura, Thrombocytopenic, Idiopathic | Chronic Thrombocytopenia | Acute Idiopathic Thrombocytopenic PurpuraNetherlands
-
BiogenTerminatedType 2 Diabetes | Chronic Kidney Disease
-
TakedaCompletedSchizophreniaUnited States
-
CytokineticsEnrolling by invitationSymptomatic Hypertrophic Cardiomyopathy (HCM)United States, France, Israel, Spain, United Kingdom, Italy, Portugal, Poland, Hungary, Denmark, Netherlands, Germany, Czechia
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Vanda PharmaceuticalsCompleted
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
Janssen Research & Development, LLCBayerCompletedHeart Failure | Rheumatic Diseases | Respiratory Insufficiency | Infectious Diseases | Stroke AcuteUnited States, Poland, Ukraine, United Kingdom, Germany, Spain, Argentina, Belarus, Colombia, Israel, Mexico, Portugal, Bulgaria, Romania, Serbia, South Africa, Turkey, Canada, Australia, Netherlands, Denmark, Greece, Peru, Brazil, Russian... and more
-
University of Erlangen-Nürnberg Medical SchoolBayerRecruiting
-
PfizerCompleted
-
EstetraRecruitingSexual Dysfunction, PhysiologicalUnited States
-
Neurim Pharmaceuticals Ltd.Syneos HealthActive, not recruitingAlzheimer's DiseaseUnited States, Canada
-
PfizerTerminatedHuntington's DiseaseUnited States, Germany, Poland, United Kingdom, Canada